XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
STOCKHOLDERS' EQUITY  
Summary of activity for stock options and restricted stock

    

    

    

Weighted-

    

average

Weighted-

contractual 

Number of 

 average 

term

Aggregate 

shares

exercise price

(in years)

intrinsic value

Outstanding at January 1, 2020

2,605,730

6.73

8.92

11,706,110

Granted

75,000

8.21

Exercised

(35,814)

4.10

Forfeited

(118,750)

10.16

Expired

-

-

Outstanding at December 31, 2020

 

2,526,166

6.99

8.10

$

115,472,832

Granted

 

$

 

 

Exercised

 

(52,694)

 

4.10

 

 

Forfeited

 

(5,935)

 

4.10

 

 

Expired

 

 

 

Outstanding at December 31, 2021

2,467,537

$

7.06

6.99

$

29,503,551

Granted

2,975,000

7.00

Exercised

(142,409)

4.10

Forfeited

(164,443)

7.84

Expired

Outstanding at December 31, 2022

 

5,135,685

$

7.10

 

5.09

$

25,064,799

Exercisable at December 31, 2022

 

2,107,583

$

6.70

 

5.64

$

11,238,429

Schedule of Fair Value Assumptions

Year Ended

    

December 31, 2022

    

December 31, 2021

December 31, 2020

 

Volatility

 

88.37-89.67

%

N/A

186.91-191.05

%

Expected term (in years)

 

3.13-4.0

N/A

5.0-6.25

Risk-free rate

 

2.99-3.35

%

N/A

0.34-0.54

%

Expected dividend yield

 

%

N/A

%

Schedule of Nonvested Restricted Stock Units Activity

    

    

Weighted-average 

grant date fair 

Number of shares

value

Outstanding at January 1, 2020

 

7,091,789

 

$

7.78

Granted

 

4,909,829

 

20.34

Vested

 

(1,087,918)

 

8.40

Forfeited

 

(128,666)

 

8.70

Outstanding at December 31, 2020

 

10,785,034

 

13.38

Granted

 

2,738,974

 

39.49

Vested

 

(1,302,737)

 

18.14

Forfeited

 

(189,231)

 

21.80

Outstanding at December 31, 2021

 

12,032,040

18.67

Granted

 

5,179,201

 

12.75

Vested

 

(6,291,999)

 

11.28

Forfeited

 

(2,186,956)

 

22.44

Outstanding at December 31, 2022

 

8,732,286

$

16.12